Get a quote

We're excited to learn more about your project and provide you with a customized quote tailored to your needs. Please fill out the form below, and we'll get back to you as soon as possible.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Recombinant Mouse Tumor Necrosis Factor Receptor Superfamily Member 11B (Tnfrsf11b), C-His

Cat. No.AP2C606

Product TypeAnimal Proteins

Size

Product Overview

BioVenic's Recombinant Mouse Tumor Necrosis Factor Receptor Superfamily Member 11B (Tnfrsf11b), C-His is a recombinant protein expressed from Human Cells. Its predicted molecular weight is 45.9 kDa. The purity is>90%.

Specifications

Type Recombinant Protein
Species Mouse
Expression System Human Cells
Purity >90%
Endotoxin < 1.0 EU/μg
Predicted Molecular Weight 45.9 kDa
Physical State Lyophilized
Formulation 0.01 mol/L PBS (pH 7.2) containing 0.2% (w/v) Procline-300.

Target Information

Mouse Tumor Necrosis Factor Receptor Superfamily Member 11B (Tnfrsf11b) is a receptor protein involved in immune regulation and bone metabolism in mice. It regulates immune cell activation and function, influencing osteoporosis and autoimmune disease development. By binding to its ligand, Tnfrsf11b regulates cell survival and apoptosis. Changes in Tnfrsf11b expression and function serve as an important indicator of immune-related diseases and bone metabolic disorders.

Protein Mouse Tumor Necrosis Factor Receptor Superfamily Member 11B (Tnfrsf11b)
Protein Synonym Osteoclastogenesis inhibitory factor; Osteoprotegerin
Gene ID 18383
UniProt ID O08712

Shipping and Storage

This product is shipped with ice packs. Lyophilized protein can be stored at -20°C for 1 year. After reconstitution, the protein solution can be stored at 2-8°C for 2-7 days.

Documents

COA

To request a Certificate of Analysis, please enter the Lot No. in the search box. Note: Certificate of Analysis not available for kits.

The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.

User Note

  1. Always centrifuge tubes before opening. Avoid mixing by vortexing or pipetting. Aliquot the reconstituted solution to minimize freeze-thaw cycles.
Inquiry Basket